(0.02%) 5 071.63 points
(-0.11%) 38 461 points
(0.10%) 15 713 points
(-0.62%) $82.84
(-9.27%) $1.644
(-0.56%) $2 328.90
(-0.61%) $27.20
(-1.11%) $912.60
(0.06%) $0.935
(0.74%) $10.98
(-0.07%) $0.803
(-0.93%) $92.32
Live Chart Being Loaded With Signals
Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. It sells prescription pharmaceuticals, reagents, medical devices and materials, OTC drugs, health foods, preventive care, clinical care, community healthcare linkage, and home medical and nursing care, as well as provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment...
Stats | |
---|---|
Today's Volume | 178 800 |
Average Volume | 272 486 |
Market Cap | 229.69B |
EPS | ¥0 ( 2024-02-07 ) |
Next earnings date | ( ¥32.58 ) 2024-05-09 |
Last Dividend | ¥16.00 ( 2023-03-30 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 15.38 |
ATR14 | ¥1.783 (0.05%) |
Volume Correlation
Toho Holdings Co., Ltd. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Toho Holdings Co., Ltd. Correlation - Currency/Commodity
Toho Holdings Co., Ltd. Financials
Annual | 2022 |
Revenue: | ¥1 388.57B |
Gross Profit: | ¥110.82B (7.98 %) |
EPS: | ¥196.69 |
Q3 | 2023 |
Revenue: | ¥384.70B |
Gross Profit: | ¥28.32B (7.36 %) |
EPS: | ¥73.14 |
Q2 | 2023 |
Revenue: | ¥383.67B |
Gross Profit: | ¥29.74B (7.75 %) |
EPS: | ¥112.26 |
Q1 | 2023 |
Revenue: | ¥351.18B |
Gross Profit: | ¥26.89B (7.66 %) |
EPS: | ¥23.06 |
Financial Reports:
No articles found.
Toho Holdings Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥16.00 (N/A) |
¥0 (N/A) |
¥16.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥10.00 | 2003-03-26 |
Last Dividend | ¥16.00 | 2023-03-30 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 39 | -- |
Total Paid Out | ¥366.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.39 | -- |
Div. Sustainability Score | 9.92 | |
Div.Growth Potential Score | 3.40 | |
Div. Directional Score | 6.66 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8135.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
7482.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6706.T | Ex Dividend Junior | 2023-09-28 | Annually | 0 | 0.00% | |
6055.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
4732.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3978.T | Ex Dividend Knight | 2023-12-28 | Annually | 0 | 0.00% | |
3186.T | Ex Dividend Junior | 2023-11-29 | Annually | 0 | 0.00% | |
2180.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
9048.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
7940.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0121 | 1.500 | 9.76 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0218 | 1.200 | 9.27 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0723 | 1.500 | -0.308 | -0.462 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.235 | 0.800 | 8.83 | 7.06 | [1 - 3] |
quickRatioTTM | 0.959 | 0.800 | 9.07 | 7.25 | [0.8 - 2.5] |
cashRatioTTM | 0.253 | 1.500 | 9.70 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0452 | -1.500 | 9.25 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 247.52 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 207.28 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 207.28 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.149 | -1.500 | 9.40 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0784 | 1.000 | -2.03 | -2.03 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0109 | 1.000 | -1.782 | -1.782 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.366 | 1.000 | 9.08 | 9.08 | [0.2 - 2] |
assetTurnoverTTM | 1.802 | 0.800 | 1.321 | 1.057 | [0.5 - 2] |
Total Score | 9.92 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 13.57 | 1.000 | 8.73 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0723 | 2.50 | -0.198 | -0.462 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 207.28 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.108 | 1.500 | 7.31 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 207.28 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.299 | 1.500 | -1.340 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.00916 | 1.000 | -2.27 | 0 | [0.1 - 0.5] |
Total Score | 3.40 |
Toho Holdings Co., Ltd.
Toho Holdings Co., Ltd. engages in the wholesale distribution of pharmaceutical products in Japan. It sells prescription pharmaceuticals, reagents, medical devices and materials, OTC drugs, health foods, preventive care, clinical care, community healthcare linkage, and home medical and nursing care, as well as provides support services, including the development and sale of customer support systems, assistance in the start-up of medical institutions and pharmacies, management consulting services, medical support, and personnel recruitment. The company also engages in dispensing pharmacy business; manufacture and sale of generic drugs; and site management organization business that assists various medical institutions with clinical trials under contract, as well as sells software to medical institutions. In addition, it provides various customer support systems, including ENIF, an information terminal for pharmaceutical ordering; ENI-Pharmacy, a support system for the separation of dispensing and prescribing functions; LXMATE HeLios a medical care appointment system; KAITOS, an online medical consultation and medication guidance system; ENIFwin, an inventory control system for large hospitals; ENIFvoice SP/ ENIFvoice SP + A/ ENIFvoice Core, a supporting system for electronic medication history recording with voice recognition; and ENIF Nurse, an operation support terminal for home-visit nurses; and logistics systems. The company was incorporated in 1948 and is headquartered in Tokyo, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators